{
    "id": 32618,
    "fullName": "ELAVL1 - TYK2",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "ELAVL1-TYK2 results from the fusion of ELAVL1 and TYK2, which leads to increased Pim1/2 expression and activation of Stat3/5 in cultured cells (PMID: 27189703). ELAVL1-TYK2 has been identified in acute myeloid leukemia (PMID: 27189703).",
            "references": [
                {
                    "id": 17889,
                    "pubMedId": 27189703,
                    "title": "Next-generation sequencing identifies a novel ELAVL1-TYK2 fusion gene in MOLM-16, an AML cell line highly sensitive to the PIM kinase inhibitor AZD1208.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27189703"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1994,
        "geneSymbol": "ELAVL1",
        "terms": [
            "ELAVL1",
            "ELAV1",
            "Hua",
            "HUR",
            "MelG"
        ]
    },
    "variant": "ELAVL1 - TYK2",
    "createDate": "02/19/2020",
    "updateDate": "02/28/2020",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 7297,
                "geneSymbol": "TYK2",
                "terms": [
                    "TYK2",
                    "IMD35",
                    "JTK1"
                ]
            }
        }
    ],
    "evidence": [
        
    ],
    "molecularProfiles": [
        {
            "id": 35202,
            "profileName": "ELAVL1 - TYK2",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}